Previous Issue - Issue 60
Issue 60 | 2025
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Expert Corner
- Advertorials
- BioPharma Go to Digital Magazine
Issue 60
PREVIOUS ISSUE
Foreword
The AI Revolution
Redefining patient outcomes across healthcare and pharma
Across Asia healthcare and life sciences are undergoing a defining transformation fuelled by the rapid advancement
Strategy
The Strategic Imperative to Solve the Local Literature Monitoring Problem
The monitoring and prevention of adverse drug events which forms the core of Pharmacovigilance PV
How Collaboration and Expertise are Reshaping Regulatory Efficiency in Southeast Asia’s Pharmaceutical Sector
Southeast Asias pharmaceutical industry is undergoing a significant transformation With a population exceeding
Research & Development
How CROs are Driving Pharmaceutical R&D
Global pharmaceutical giants rely on the burgeoning Contract Research Organization CRO sector to accelerate
Advancing Toxicology and Drug Testing
The use of live invertebrate models
The advancement of novel chemicals and formulations across diverse applications underscores the strong need
Clinical Trials
Decentralised Clinical Trials
Transforming the future of patient-centric research
With patient centricity at their core and supported by a conducive regulatory landscape decentralised clinical trials
Manufacturing
Advancements in Thin Layer Chromatography
A cornerstone in pharmaceutical analysis
Thin Layer Chromatography TLC has long stood as a cornerstone technique in the separation and analysis of compounds
Gene to GMP Challenges and Opportunities in Gene Therapy Manufacturing
Gene Therapy is a medicinal technique which delivers genes to treat or prevent a genetic disease
Information Technology
The AI Revolution in Asian Healthcare
Stratifying resources for improved patient outcomes
The landscape of global health is at a critical juncture While medical advancements continue to push the boundaries
Expert Corner
OLIGONUCLEOTIDE THERAPEUTICS
Where are we and what lies ahead
I think the past decade truly represents a watershed moment for oligo therapeutics We witnessed the dramatic
Navigating Regulatory Complexities in Global Clinical Trials
The New Drugs and Clinical Trials Rules represented a watershed moment in Indias regulatory approach
Digital Twins in Autonomous Biomanufacturing and Precision Engineering for Next-generation RNA Vaccines
The integration of AI with digital twins DTs revolutionises LNP optimisation through multiscale modeling approaches
PARADIGM SHIFT TOWARDS THE DEVELOPMENT OF BIODEGRADABLE DRUGS
The increasing recognition of pharmaceutical contamination in the environment has led to a shift in thinking
Why the Pharmaceutical Industry Needs CDMOs and Cold Chain Collaboration
Distribution of lifesaving pharmaceuticals across the globe is incredibly complex At each stage from warehouse
Advertorials
Pharma 4.0
Driving the future of pharma manufacturing
Pharma adapted from Industry is tailored to meet the stringent regulatory demands of the pharmaceutical industry
BioPharma
Optimising Biologics Manufacturing in APAC
How Next-Gen Resins Are Powering Bioprocessing Efficiency
As the global demand for biologics continues to surge the AsiaPacific APAC region is rapidly emerging
